201 related articles for article (PubMed ID: 36761480)
61. Integrated Analysis of the Immune Infiltrates and PD-L1 Expression of N6-Methyladenosine-Related Long Non-Coding RNAs in Colorectal Cancer.
Jiang Z; Zhang Y; Chen K; Yang X; Liu J
Int J Gen Med; 2021; 14():5017-5028. PubMed ID: 34511985
[TBL] [Abstract][Full Text] [Related]
62. Comprehensive Analysis of N6-Methyladenosine-Related Long Noncoding RNA Prognosis of Acute Myeloid Leukemia and Immune Cell Infiltration.
Zheng G; Liu M; Chang X; Cao X; Dong A; Zhu H; Hu W; Xie J; Zhao Y; Hu D; Jia X; Yang Y; Shi X; Lu J
Front Genet; 2022; 13():888173. PubMed ID: 35601490
[TBL] [Abstract][Full Text] [Related]
63. Identification of m6A-Related lncRNAs Associated With Prognoses and Immune Responses in Acute Myeloid Leukemia.
Li D; Liang J; Cheng C; Guo W; Li S; Song W; Song Z; Bai Y; Zhang Y; Wu X; Zhang W
Front Cell Dev Biol; 2021; 9():770451. PubMed ID: 34869365
[No Abstract] [Full Text] [Related]
64. The Role of m6A RNA Methylation-Related lncRNAs in the Prognosis and Tumor Immune Microenvironment of Papillary Thyroid Carcinoma.
Wang W; Shen C; Zhao Y; Sun B; Qiu X; Yin S; Chen J; Li X
Front Cell Dev Biol; 2021; 9():719820. PubMed ID: 35047491
[TBL] [Abstract][Full Text] [Related]
65. AL360181.1 promotes proliferation and invasion in colon cancer and is one of ten m6A-related lncRNAs that predict overall survival.
Luo Y; Xie Y; Wu D; Wang B; Lu H; Wang Z; Quan Y; Han B
PeerJ; 2023; 11():e16123. PubMed ID: 37953780
[TBL] [Abstract][Full Text] [Related]
66. Prognostic Value of Genomic Instability of m
Li R; Li JP; Liu TT; Huo C; Yao J; Ji XL; Qu YQ
Front Cell Dev Biol; 2022; 10():707405. PubMed ID: 35309906
[No Abstract] [Full Text] [Related]
67. N6-methyladenosine (m6A)-connected lncRNAs are linked to survival and immune infiltration in glioma patients.
Wu WJ; Xiao F; Xiong Y; Sun GF; Guo Y; Zhou X; Hu GW; Huang K; Guo H
Biosci Rep; 2023 May; 43(5):. PubMed ID: 37083719
[TBL] [Abstract][Full Text] [Related]
68. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
69. N6-Methylandenosine-Related lncRNAs in Tumor Microenvironment Are Potential Prognostic Biomarkers in Colon Cancer.
Zhang H; Zhao L; Li S; Wang J; Feng C; Li T; Du X
Front Oncol; 2021; 11():697949. PubMed ID: 34178697
[TBL] [Abstract][Full Text] [Related]
70. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
71. Prognostic analysis of m6A-related lncRNAs as potential biomarkers in intrahepatic cholangiocarcinom.
Shi G; Wang J; Wang W; Chen M; Liu X; Zheng Y; Fu Y; Wang M; Zhang X
Front Genet; 2022; 13():982707. PubMed ID: 36160000
[TBL] [Abstract][Full Text] [Related]
72. Bioinformatic identification reveals a m6A-binding protein, IGF2BP2, as a novel tumor-promoting gene signature in thyroid carcinoma.
Xie Y; Xiao J; Ying Y; Liu J; Zhang L; Zeng X
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; ():. PubMed ID: 38289368
[TBL] [Abstract][Full Text] [Related]
73. N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia.
Zhang L; Ke W; Hu P; Li Z; Geng W; Guo Y; Song B; Jiang H; Zhang X; Wan C
Front Genet; 2022; 13():804614. PubMed ID: 35615374
[No Abstract] [Full Text] [Related]
74. N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.
Tu Z; Wu L; Wang P; Hu Q; Tao C; Li K; Huang K; Zhu X
Front Cell Dev Biol; 2020; 8():642. PubMed ID: 32793593
[TBL] [Abstract][Full Text] [Related]
75. N6-Methyladenosine-Related Long Noncoding RNAs as Potential Prognosis Biomarkers for Endometrial Cancer.
Shi R; Wang Z; Zhang J; Yu Z; An L; Wei S; Feng D; Wang H
Int J Gen Med; 2021; 14():8249-8262. PubMed ID: 34815698
[TBL] [Abstract][Full Text] [Related]
76. Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma.
Chen Y; Guo Y; Li S; Xu J; Wang X; Ning W; Ma L; Qu Y; Zhang M; Zhang H
Front Oncol; 2022; 12():789283. PubMed ID: 35311131
[TBL] [Abstract][Full Text] [Related]
77. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
Wu J; Cai Y; Zhao G; Li M
J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391
[TBL] [Abstract][Full Text] [Related]
78. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
79. Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma.
Chen Z; Zhang W; Yan Z; Zhang M
Cancer Med; 2023 Jan; 12(1):760-788. PubMed ID: 35668574
[TBL] [Abstract][Full Text] [Related]
80. Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer.
Lv W; Wang Y; Zhao C; Tan Y; Xiong M; Yi Y; He X; Ren Y; Wu Y; Zhang Q
Front Oncol; 2021; 11():745719. PubMed ID: 34722303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
